The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Successful completion of EGFR/ALK testing in non-squamous non-small cell lung cancer (non-sq NSCLC) with the implementation of reflex testing (RT) by pathologists.
 
Ines B. Menjak
No Relationships to Disclose
 
Zoe Winterton-Perks
No Relationships to Disclose
 
Simon Raphael
Speakers' Bureau - Boehringer Ingelheim; Novartis
 
Susanna Y. Cheng
No Relationships to Disclose
 
Sunil Verma
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Novartis; Roche
 
Ryan Freedman
Employment - Cardiomatters (I); VitalityMD (I)
Leadership - Cardiomatters (I); VitalityMD (I)
Stock and Other Ownership Interests - Cardiomatters (I); VitalityMD (I)
Consulting or Advisory Role - Cardiomatters (I)
Travel, Accommodations, Expenses - VitalityMD (I)
 
Nevkeet Toor
No Relationships to Disclose
 
Joseph Perera
No Relationships to Disclose
 
Matthew Anaka
Stock and Other Ownership Interests - ArQule; Bluebird Bio; Bristol-Myers Squibb; Foundation Medicine; Gilead Sciences; Halozyme; Novartis; Roche; Sangamo Bioscience; Vertex
 
Charles Victor
No Relationships to Disclose
 
Parneet Kaur Cheema
Honoraria - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Novartis; Pfizer
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Pfizer
Research Funding - AstraZeneca; Boehringer Ingelheim; Roche
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Boehringer Ingelheim; Pfizer; Roche